Handforth, Adrian <br/><br/>
Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome.  [electronic resource] 

 -  Epilepsia  Dec 2005 
 - 1860-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0013-9580 
<br/><br/><label>Standard No.: </label>10.1111/j.1528-1167.2005.00287.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angelman Syndrome--drug therapy<br/>Animals<br/>Anticonvulsants--pharmacology<br/>Baclofen--pharmacology<br/>Cerebral Cortex--drug effects<br/>Disease Models, Animal<br/>Electrodes, Implanted<br/>Electroencephalography--drug effects<br/>Ethosuximide--pharmacology<br/>Female<br/>GABA Agonists--pharmacology<br/>GABA Antagonists--pharmacology<br/>Humans<br/>Male<br/>Mice<br/>Mice, Mutant Strains<br/>Neural Pathways--physiopathology<br/>Organophosphorus Compounds--pharmacology<br/>Parietal Lobe--physiopathology<br/>Receptors, GABA-A--deficiency<br/>Thalamus--drug effects